Search Results

Displaying Results 1-1 of 1 "'INMB'"

May 19, 2026, 09:00 ET Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes

Inc. (NASDAQ: GTBP), Fate Therapeutics, Inc. (NASDAQ: FATE), Nkarta, Inc. (NASDAQ: NKTX), ImmunityBio, Inc. (NASDAQ: IBRX), INmune Bio, Inc. (NASDAQ: INMB)SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- The case for natural killer

More news about: Equity Insider


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.